secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMERICAN VANGUARD CORP (AVD)
CIK:        0000005981
Form:       8-K
Filed at:   2022-11-10T23:59:59+00:00
Accession:  0001193125-22-282425
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

American Vanguard Q3 EPS $0.23 (+27.8% YoY); adj. EBITDA view ~$80M
-------------------------------------------------------------------

- Q3 net sales $152M (+3.4% YoY), net income $6.7M (+21.8%), diluted EPS $0.23.
- Nine-month net sales $450M (+13.1%), net income $23.5M (+71.5%), EPS $0.78.
- Full-year adj. EBITDA target ~$80M (13% of expected sales), exceeding prior 24-28% growth range.
- Repurchased 1.5M shares YTD via ASR and 10b5-1 plan.
- Secured Counter nematicide registration for soybeans in Brazil; alliance with NewLeaf Symbiotics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/5981/000119312522282425/0001193125-22-282425-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/5981/000119312522282425/d125853d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-282425

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer